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Arrestin (also named '48 kDa protein' or 'S-antigen') is a soluble protein involved in controlling light-depen- 
dent cGMP phosphodiesterase ctivity in retinal rods, and is also known for its ability to induce autoim- 
mune uveitis of the eye. We report a rapid and simple purification method based on the property of arrestin 
to bind specifically and reversibly to illuminated and phosphorylated rhodopsin [(1984) FEBS Lett. 176, 
473 478]. This method oes not require column chromatography and yields about 2--4 mg purified arrestin 
from 15 bovine retinas. Pure arrestin can be resolved by isoelectric focusing into at least 10 distinct bands, 
all of which stain with a monoclonal antibody specific for S-antigen. 
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1. INTRODUCTION 
Arrestin (previously called '48 kDa protein') is 
one of the most abundant soluble proteins of the 
vertebrate photoreceptor cell [1] and is presently 
being investigated in many laboratories for dif- 
ferent reasons. Since its discovery in 1978, as one 
among three proteins which bind to the ROS disk 
membrane in a light-dependent manner [2], it has 
recently attracted interest for two reasons. Firstly, 
it has been shown to play an important role in the 
light-induced enzyme cascade of vision: it binds to 
photoisomerized and phosphorylated rhodopsin 
[3] and thereby quenches rhodopsin's capacity to 
activate PDEase [4]. This function has led to its 
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Abbreviations: ROS, rod outer segment; PDEase, 
cGMP phosphodiesterase; IEF, isoelectric focusing; 
SDS-PAGE, polyacrylamide gel electrophoresis in the 
presence of SDS; FPLC, fast protein liquid 
chromatography 
name 'arrestin' [5]. Secondly, arrestin has been 
shown to be identical with 'retinal S-antigen' [6], 
a retina protein known to cause experimental 
autoimmune uveitis when injected into animals. 
Some methods have been published, describing the 
purification of retinal S-antigen [7-10], all of  
which involve several time-consuming column 
chromatographic steps. We report a rapid and sim- 
ple method which takes advantage of the ability of  
arrestin to associate reversibly with bleached and 
phosphorylated rhodopsin. 
2. MATERIALS AND METHODS 
ROS were prepared from fresh bovine retinas as 
described [ii]. 
2.1. Retina extract 
Retina extract was prepared in dim red light as 
follows. 150 retinas that had been frozen in liquid 
Nz were thawed in 200 ml of 70 mM sodium 
phosphate buffer (pH 7.2)/2 mM MgCI2/0.1 mM 
EDTA. They were shaken vigorously by hand for 
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1 inin and then gently stirred for 30 min on ice. 
After centrifugation for 30 rain at 20000 rpm in a 
Beckman .IA 20 rotor, the supernatant was col- 
lected and centrifuged again. The final supernatant 
was stored at - 80°C in aliquots of 20 ml until use. 
2.2. Arrestin purification 
An ROS pellet containing -15 mg rhodopsin 
was homogenized in 15 ml of 70raM sodium 
phosphate (pH 7.2)/2 mM MgCI2/0.1 mM 
EDTA/3 mM ATP/1 mM GTP and illuminated at 
30°C with white light (150 W). After 20 rain, 
20 ml retina extract, which had been separately 
warmed to 30°C, was added, and the mixture was 
illuminated for another 10 rain. The suspension 
was centrifuged for 20 rain at 20000 rpm. The 
supernatant was discarded and the pellet washed 
twice by resuspending it each time with 30 ml of 
10 mM Hepes (pH 7.2) at 4°C and centrifuging for 
40 rain at 20000 rpm. In the first washing, 0.1 mM 
GTP was additionally present. The final pellet was 
suspended in 5 ml of 2 mM Hepes (pH 
7.2)/500 mM KC1 and incubated at 4°C overnight. 
The suspension was then centrifuged at 20000 rpm 
for 20 rain. The supernatant containing the 
purified arrestin was centrifuged again to remove 
any residual membrane particles and was frozen in 
small aliquots and stored at -80°C until use. (If 
a salt-free preparation is desired, the final pellet 
can be extracted with 5 ml of 300 mM (NH4)HCO3 
instead of 500 mM KCI. The buffer can then be 
removed by lyophilization without loss of activity 
of the purified arrestin.) 
2.3. Isoelectric focusing 
IEF was carried out on vertical slab gels (135 x 
170 × 1 ram), containing 5% polyacrylamide, 407o 
ampholines (LKB) (pH 5-7), 1% ampholines (pH 
3.5-10), and normally 0.5% octylglucoside. Elec- 
trode solutions were 20 mM NaOH and 50 mM 
HaPO4. Focusing power was usually 2500 V. h. 
For immunoblotting the proteins were trans- 
ferred to nitrocellulose sheets [12] and stained 
using the anti-S-antigen monoclonal antibody 
$6H8 (kind gift of J.P. Faure, see [13]) and the 
biotin-streptavidin system (Amersham), with 
1-chloro-4-naphthol as a substrate. 
2.4. Phosphodiesterase activity 
Phosphodiesterase activity was monitored 
through the pH changes associated with cGMP 
hydrolysis [4,14]. Phosphorylated ROS mem- 
branes (P-disks) for PDEase assay were prepared 
as in [31. 
3. RESULTS AND DISCUSSION 
The affinity purification procedure described 
here makes use of the specific and reversible 
binding of arrestin to bleached and phosphor- 
ylated rhodopsin [3]. During the illumination 
period in the presence of ATP, rhodopsin becomes 
phosphorylated and therefore binds arrestin; other 
proteins are removed by centrifugation, and the 
purified arrestin is then eluted from the mem- 
branes simply by an overnight incubation in the 
dark in high ionic strength buffer. 
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Fig.l. Polypeptide composition [15] of arrestin as 
prepared using our method (lanes 4,6,7,8) or that of 
Dorey et al. [8] (lanes 5,9,10). Lanes 1-5 were stained 
with Coomassie blue and lanes 6-10 by silver staining 
[16]. Lanes 4-7, 9 and 10 each contained 5,ag protein 
[17], lane 8 contained 2/xg. Lane 1, supernatant (5/zl) 
obtained after mixing retina extract with bleached ROS; 
lanes 2,3, 20/A and 50/zl, respectively, of the two 
successive washing supernatants ( ee section 2); lanes 
4,6, crude arrestin, prepared by our method; lane 8, 
after further purification by an additional wash (see 
text); lanes 5,9, crude arrestin, prepared according to 
Dorey et al. [8]. Aliquots of crude arrestin obtained 
either by our method or by that of Dorey et al. [8] were 
further purified by FPLC (Pharmacia Mono Q column, 
see [18]); the resulting preparations are shown on lanes 
7 and 10, respectively. 
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Fig. 1 shows that the resulting arrestin prepara- 
tion is at least as pure as a typical preparation 
purified by a conventional column chromato- 
graphic method [8]. The two crude preparations 
contain a different set of impurities (cf. lanes 6 and 
9, fig. 1). The yield is normally 2-4 mg arrestin for 
15 retinas. This preparation normally contains 
some rhodopsin kinase activity which can be 
removed by a subsequent FPLC chromatographic 
step. FPLC purification of our crude arrestin 
yields a preparation which is essentially pure by the 
criterion of silver staining on SDS-PAGE (5/xg 
protein, see lane 7, fig. 1). 
The advantage of our 'crude' purification pro- 
cedure is its simplicity and rapidity as compared 
with conventional procedures involving successive 
column chromatographic steps [7-10]. Our pro- 
cedure takes only about 3 h on 1 day and 1 h on 
the following morning, and requires no more than 
a few centrifugation steps. It yields a product at 
least as pure as the column chromatographic 
methods (see fig.l) and can easily be scaled up by 
a factor of 10 or more. 
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Fig.3. Isoelectric focusing pattern of different arrestin 
preparations (10,ag protein each). Lanes: 1-4, staining 
with Coomassie blue; 5-8, corresponding immunoblot. 
Lanes: 1,2, arrestin preparation according to Dorey et 
al. [8], in lane 1 further purified by FPLC; 3,4, 
preparation according to our method, in lane 3 further 
purified by FPLC. The 4 preparations shown here are 
the same as those shown in fig.l, lanes 10, 9, 7 and 6, 
respectively. More bands are seen on the immunoblot 
than on the Coomassie blue-stained gel because of the 
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Fig.2. Inhibition of light-induced PDEase activity by 
arrestin purified by our method (A) or according to 
Dorey et al. [8] (B). PDEase activity was measured with 
purified transducin and PDEase reassociated to 
phosphorylated and regenerated rod outer segment 
membranes as in [4]. Each sample contained 5 nmol 
rhodopsin, 0.04 nmol PDEase and 0.6 nmol transducin 
in a final volume of 1.4 ml. Initial concentration of 
cGMP was 1.5 mM, and of GTP 0.1 mM in 10mM 
Hepes (pH 7.9)/120mM KCI (2mM MgCI2. The 
reaction was started by a flash bleaching 10 -4 Of the 
rhodopsin. Amounts of arrestin (,ug) added to the 
various samples are indicated on the curves. 
A nearly pure arrestin preparation can be 
achieved even in the absence of FPLC, if an addi- 
tional centrifugation step is included (fig.l, lane 
8). Washing the pellet gently and briefly (see sec- 
tion 2) with 3-5 ml of 2 mM Hepes/500 mM KC1, 
before its overnight incubation in the same buffer, 
removes most of the impurities present in the crude 
preparation (fig. l, lane 6) with relatively small 
losses ( -30%) of arrestin. 
Fig.2 compares the activity [4] of our arrestin 
preparation with that of a preparation by Dorey et 
al. [8]. Both preparations are equally active in sup- 
pressing light activation of PDEase in the presence 
of phosphorylated rhodopsin [4]. 
IEF resolves arrestin into a number of 
subspecies (fig.3) as mentioned earlier [9,17]. Even 
FPLC-purified arrestin, which is essentially 
homogeneous on SDS-PAGE, is resolved into 2-4 
major bands and 5-10 minor bands with isoelec- 
tric points between pH 5.5 and 6.1. All of these 
subspecies are stained by an antibody specific [13] 
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for S-antigen (= arrestin; see fig.3, lanes 5-8). 
Qualitatively similar 1EF patterns are observed 
with arrestin purified by our method or that of 
Dorey et al. [8], either crude or FPLC-purified 
(fig.3, lanes 5-8). Specificity of the antibody was 
verified by blotting an SDS gel containing all of the 
soluble proteins of the retina (similar to lane 1 in 
fig. l): only arrestin was recognized by the an- 
tibody. The IEF pattern was the same in the 
presence (fig.3) or absence (not shown) of oc- 
tylglucoside, and was the same at 4 or 20°C. Par- 
tial preparative separation of the subspecies could 
be achieved by careful fractionation on the Mono 
Q column, as well as by differential elution from 
the disk membranes (not shown). This indicates 
that the observed multiplicity is not an IEF 
artefact. Addition of a mixture of protease in- 
hibitors (phenylmethylsulfonyl f uoride, ben- 
zamidine, leupeptin, aprotinine, EGTA)dur ing  
purification did not change the IEF patlern. 
The observed multiplicity of IEF subspecies may 
be partially due to phosphorylation of arrestin 
(Weyand, I., unpublished), and perhaps to addi- 
tional factors which are at present unknown. Such 
multiplicity raises the question of whether the dif- 
ferent subspecies may play differential roles in 
regulating PDEase activity [4], and/or in causing 
the autoimmune disease [6-8]. 
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